Echo® MS+ system
Don’t compromise – obtain high-quality data, at speed
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
When the quantity of samples is your challenge, breakthrough with Echo® MS+ systems. The Echo® MS+ systems give you high-quality data, analytical flexibility and high sample throughput that SCIEX can provide so you can make the right decisions, today. With sampling rates of up to 1 sample/second, you can have results on the same day they are submitted to your lab. The Echo® MS+ system is a complete solution that removes bottlenecks in high-throughput analytical workflows, from sample preparation to data reporting.
How to map disease-specific changes using innovative LC-MS/MS-based omics approaches
June 26, 2025 – 16:00 BST / 17:00 CEST / 11:00 EDT / 08:00 PDT
Mass spectrometry coupled with liquid chromatography (LC-MS/MS) has become a cornerstone of clinical research for the analysis of biomarkers indicative of disease. The integration of this technology across omics applications provides significant advantages in terms of assay sensitivity, specificity, robustness, and multiplexing. These benefits are enabling researchers to gain new insights into disease etiology and pathogenesis through the identification and quantitation of disease-specific biomarkers.
In this webinar, Professor Martin Giera, Leiden University Medical Center and Professor Antonin Lamazière, Sorbonne University and Saint Antoine’s Hospital, will demonstrate how the latest advancements in mass spectrometry-based omics are providing a comprehensive assessment of disease mechanisms and patient-specific treatment responses.
The presentations will showcase several examples of how the integration of LC-MS/MS technology across various omics applications provides disease state evaluation and monitoring, ultimately resulting in more personalized and effective patient care.
Key learning objectives
- Learn best practices for the development and implementation of LC-MS/MS assays for biomarker identification and quantitation
- Discover novel, LC-MS/MS-based metabolomic and lipidomic workflows that provide semiologic indications and understanding of disease pathogenesis
- Explore recent technological advancements in LC-MS/MS hardware and bioinformatics improving performance for biomarker discovery and quantitation
- Understand the benefits of sensitive MS techniques to establish mapping of changes in the human lipidome and metabolome linked to disease onset and progression
Who should attend?
Anyone in a clinical laboratory interested in the development of LC-MS/MS-based clinical research, biomarker discovery, and assay development. Clinical researchers, healthcare professionals, biomarker discovery experts, laboratory directors, scientists, method/assay developers, and laboratory personnels who wish to learn about best practices for assay development and LC-MS/MS methods to accurately and reliability characterize, identify, and quantify biomarkers in clinical samples.
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Addressing cell line development barriers with advanced analytics
In this SelectScience interview, explore key challenges, analytical solutions and future directions in cell line development
SCIEX launches high-throughput screening solutions at SLAS2024
The Echo MS+ system unlocks enhanced high-throughput screening capability
